Arsenic nano complex induced degradation of YAP sensitized ESCC cancer cells to radiation and chemotherapy

[1]  Henry W. Long,et al.  Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway. , 2020, Cancer cell.

[2]  J. Lippincott-Schwartz,et al.  Phase separation of YAP reorganizes genome topology for long-term YAP target gene expression , 2019, Nature Cell Biology.

[3]  M. Voso,et al.  Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies , 2019, Cancers.

[4]  Y. Duan,et al.  Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment. , 2019, Signal transduction and targeted therapy.

[5]  Qiang Zhou,et al.  Phase separation of TAZ compartmentalizes the transcription machinery to promote gene expression , 2019, Nature Cell Biology.

[6]  X. Pei,et al.  Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex , 2019, Cell Death & Disease.

[7]  A. Dey,et al.  Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities. , 2019, Trends in cancer.

[8]  W. Fang,et al.  (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia , 2019, Drug delivery.

[9]  J. Ajani,et al.  YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer – Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer , 2018, Clinical Cancer Research.

[10]  Lianghai Wang,et al.  Unbalanced YAP–SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma , 2018, Oncogene.

[11]  Xiaoyuan Chen,et al.  Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors. , 2018, ACS nano.

[12]  S. Bicciato,et al.  Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4 , 2018, Nature Medicine.

[13]  F. Xiong,et al.  Role of YAP in lung cancer resistance to cisplatin. , 2018, Oncology letters.

[14]  P. Khanal,et al.  The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. , 2018, Cancer research.

[15]  E. Shin,et al.  YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma , 2018, Cancer Immunology Research.

[16]  D. Zuo,et al.  Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma , 2017, Free radical biology & medicine.

[17]  Saijuan Chen,et al.  Poisoning the Devil , 2017, Cell.

[18]  Yan-li Meng,et al.  Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: Long‐term outcome analysis , 2017, Journal of gastroenterology and hepatology.

[19]  Benjamin J. Raphael,et al.  Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.

[20]  Morteza Mahmoudi,et al.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. , 2016, Nature nanotechnology.

[21]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[22]  E. Oki,et al.  An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression. , 2015, Cancer research.

[23]  G. G. Galli,et al.  YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers. , 2015, Molecular cell.

[24]  J. Ajani,et al.  The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer , 2015, Clinical Cancer Research.

[25]  Qiang Feng,et al.  Identification of genomic alterations in oesophageal squamous cell cancer , 2014, Nature.

[26]  V. Grégoire,et al.  Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. , 2012, Cancer research.

[27]  Zi-yu Wang,et al.  Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells , 2011, International journal of nanomedicine.

[28]  G. Varani,et al.  Faculty Opinions recommendation of Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. , 2010 .

[29]  Jian-Hua Tong,et al.  Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML , 2010, Science.

[30]  P. Pandolfi,et al.  PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. , 2008, Molecular cell.

[31]  M. Lei,et al.  Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway , 2008, Nature Cell Biology.

[32]  N. Buttar,et al.  COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett’s oesophagus and oesophageal adenocarcinoma , 2007, Gut.

[33]  Yuan Zhang,et al.  Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts. , 2004, Oncology reports.

[34]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..